CSPC Pharmaceutical Group Ltd (NASDAQ:CHPTY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Tuesday.

According to Zacks, “CSPC Pharmaceutical Group Limited operates as a pharmaceutical group in China. Its bulk drug products include vitamin C, penicillin G and 7-ACA. The Company is also a major manufacturer of antibiotic finished drugs such as penicillin and cephalosporin products. CSPC Pharmaceutical Group Limited, formerly known as China Pharmaceutical Group Limited, is based in Wan Chai, Hong Kong. “

CSPC Pharmaceutical Group (NASDAQ:CHPTY) traded up 9.24% during midday trading on Tuesday, hitting $80.04. The company had a trading volume of 43 shares. CSPC Pharmaceutical Group has a 52 week low of $51.03 and a 52 week high of $80.04. The firm has a market capitalization of $9.69 billion and a P/E ratio of 32.02. The firm’s 50 day moving average is $79.29 and its 200-day moving average is $72.88.

TRADEMARK VIOLATION NOTICE: This piece was first posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/10/24/zacks-investment-research-downgrades-cspc-pharmaceutical-group-ltd-chpty-to-hold.html.

CSPC Pharmaceutical Group Company Profile

CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs).

Get a free copy of the Zacks research report on CSPC Pharmaceutical Group (CHPTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CSPC Pharmaceutical Group Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group Ltd and related companies with MarketBeat.com's FREE daily email newsletter.